Empowering Patients' Lung Cancer Screening Uptake

Conditions

• Lung Cancer

Eligibility Criteria

Sex

ALL

Age

50 Years - 80 Years

Healthy Volunteers

Accepted

Interventions

• Patient education — BEHAVIORAL
  Patients will be sent information (in preferred language) on lung cancer risk, lung cancer screening (LCS) benefits, harms, false positive rates, recommendations of follow-up for positive results, and exam insurance coverage.
• Referral to financial navigation resources — BEHAVIORAL
  Patients who self-report needing help with health-related social risks at baseline will be sent a brochure (in preferred language) from patient advocate foundation (PAF), a national non-profit financial navigation organization, where patients can self-refer.
• Patient Reminders — BEHAVIORAL
  Within 2 weeks prior to primary care appointment, patients will receive a text message or a phone call (if not having a phone that receives text messaging) encouraging patients to discuss the LCS with their provider.
• Provider Reminers — BEHAVIORAL
  Within 2 weeks prior to primary care appointment, providers will be notified of their patient's eligibility for LCS.

Study Details

Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test the effect of a a multi-level intervention on ordering LDCT within 6 months after patient enrollment. Our proposed intervention includes (1) Primary care provider notifications of patients' LCS eligibility; (2) patients' education ; (3) patients' referral to financial navigation resources; and (4) patients' reminder to discuss LCS during PCP visit.

Key Dates

Start date

Oct 13, 2023

Status verified

Feb 2026

Primary completion

Mar 21, 2025

Completion

Nov 25, 2025

Study Design

Enrollment

79 participants (actual)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

SCREENING

Arms

• Experimental: Empower LCS
  Patient will be given education material(addressing knowledge barriers); patients' referral to financial navigation resources (addressing health-related social risks); and patients' reminder to discuss LCS during PCP visit. Providers will also be notified of eligibility of their patients to receive LCS.

Primary Outcome Measure

Order of LDCT [ Time Frame: within 6 months of enrollment ]

Locations (7)

Find similar trials in Costa Mesa, CA

Related Studies

• Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
  Recruiting · Stanford University · Stanford, California
• Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
  Recruiting · University of California, Davis · Sacramento, California
• Molecular Analysis of Thoracic Malignancies
  Enrolling By Invitation · Stanford University · Stanford, California
• APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
  PHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California